Abstract
The first attempts to artificially sustain the circulation in modern times occurred with the development of the cardiopulmonary bypass machine by John Gibbon and later modified by John Kirklin in the mid-1950s 1 ,2. These early machines revolutionized the field of cardiac surgery, allowing complex repairs to be done while sustaining the circulation with cardiopulmonary bypass. About a decade later, the first pulsatile pumps were being used to assist the failing left ventricle, especially in patients with cardiogenic shock postcardiotomy3,4. These early reports encouraged scientists of the time, like Dr. Michael DeBakey, in a crusade to produce a device intended for long-term ventricular support5. By the late 1960s, with the birth of heart transplantation6, interest in mechanical assist devices waned. As the limitations of heart transplantation became apparent, especially the lack of adequate immunosuppression early on, renewed interest in mechanical ways of supporting the failing heart surged in the mid-1970s.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171–80.
Kirklin JW, DuShane JW, Patrick RT, et al. Intracardiac surgery with the aid of a mechanical pumpoxygenator system (Gibbon type): report of eight cases. Staff Meetings Mayo Clin 1955;30:201–6.
Frazier OH. Ventricular assist devices and artificial hearts. A historical perspective. Cardiol Clin 2003;21:1–13.
Hall CW, Liotta D, Henry WS, et al. Development of artificial intrathoracic circulatory pumps. Am J Surg 1964;108:685–92.
DeBakey ME. Left ventricular bypass pump for cardiac assistance: clinical experience. Am J Cardiol 1971;27:3–11.
Barnard CN. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 1967;41:1271–4.
Norman JC, Duncan JM, Frazier OH, et al. Intracorporeal (abdominal) left ventricular assist devices or partial artificial hearts: a five year clinical experience. Arch Surg 1981;116:1441–5.
Norman JC, Brook MI, Cooley DA, et al. Total support of the circulation of a patient with postcardiotomy stone-heart syndrome by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet 1978;1(8074):1125–7.
Portner PM, Oyer PE, McGregor CGA, et al. First human use of an electrically powered implantable ventricular assist system. Artif Organs 1985;9:36.
Rose EA, Gelijns AC, Moskowitz AJ, et al. Longterm use of a left ventricular assist device for endstage heart failure. N Engl J Med 2001;345:1435–43.
Frazier OH, Wampler RK, Duncan JM, et al. First human use of the Hemopump, a catheter-mounted ventricular assist device. Ann Thorac Surg 1990;49:299–304.
Cooley DA, Liotta D, Hallman GL, et al. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 1969;24:723–30.
DeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N Engl J Med 1984;310:273–8.
Johnson KE, Prieto M, Joyce LD, et al. Summary of the clinical use of the Symbion total artificial heart: a registry report. Ann Surg 1995;222:327–36.
Copeland JG, Smith RG, Arabia FA, et al. Cardiac replacement with a total artifical heart as a bridge to transplantation. N Engl J Med 2004;351:859–67.
Dowling RD, Gary LA Jr, Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004;127:131–41.
Spencer FC, Eiseman B, Tinkle JK, Rodd NP. Assisted circulation for cardiac failure following intracardiac surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1965;49:56–73.
Pennington DG, Bernhard WF, Golding LR, et al. Long-term follow-up of postcardiotomy patients with profound cardiogenic shock treated with ventricular assist devices. Circulation 1985;72:II216–26.
Farrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg 1993;55:276–82.
Dasse KA, Frazier OH, Lesniak JM, Myers T, Burnett CM, Poirier VL. Clinical responses to ventricular assistance versus transplantation in a series of bridge to transplant patients. ASAIO J 1992;38:M622–6.
Portner PM, Oyer PE, Pennington DG, et al. Implantable electrical left ventricular assist device: bridge to transplantation and the future. Ann Thorac Surg 1989;47:142–50.
Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 2005;129:9–17.
Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol 2006;97:1391–8.
Wolner E, Deutsch M, Losert U, et al. Clinical application of the ellipsoid left heart assist device. Artif Organs 1978;2:268–72.
Olsen EK, Pierce WS, Donachy JH, et al. A two and one half year clinical experience with a mechanical left ventricular assist pump in the treatment of profound postoperative heart failure. Int J Artif Organs 1979;2:197–206.
Guyton RA, Schonberger JP, Everts PA, et al. Postcardiotomy shock: clinical evaluation of the BVS 5000 biventricular support system. Ann Thorac Surg 1993;56:346–56.
Helman DN, Morales DL, Edwards NM, et al. Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. Ann Thorac Surg 1999;1187–94.
Pennington DG, Bernhard WF, Golding LR, et al. Long-term follow-up of postcardiotomy patients with profound cardiogenic shock treated with ventricular assist devices. Circulation 1985;72:II216–26.
Farrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg 1993;55:276–82.
Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 trial experience. The GUSTO-1 Investigators. J Am Coll Cardiol 1995;26:668–74.
Hochman JS, Sleeper LA, Webb JG, et al., for the SHOCK Investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999;341:625–34.
Hasdai D, Holmes DR Jr, Califf RM. Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Am Heart J 1999;138:21–31.
Castells E, Calbet JM, Saura E, et al. Acute myocardial infarction with cardiogenic shock: treatment with mechanical circulatory assistance and heart transplantation. Transplant Proc 2003;35:1940–1.
McBride LR. Naunheim KS. Fiore AC. Moroney DA. Swartz MT. Clinical experience with 111 Thoratec ventricular assist devices. Ann Thorac Surg 1999;67:1233–8.
Meyns B, Dens J, Sergeant P, et al. Initial experiences with the Impella device in patients with cardiogenic shock—Impella support for cardiogenic shock. Thorac Cardiovasc Surgeon 2003;51:312–7.
Thiele H, Sick P, Boudriot E, et al. randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276–83.
McCarthy RE, Boehmer JP, Hruban RH, et al. Long term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;343:690–5.
Holman WL, Bourge RC, Kirklin JK. Case report: circulatory support for seventy days with resolution of acute heart failure. J Thorac Cardiovasc Surg 1991;102:932–4.
Rockman HA, Adamson RM, Dembitsky WP, Bonar JW, Jaski BE. Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular device. Am Heart J 1991;121:922–6.
Kesler KA, Pruitt AL, Turrentine MW, Heimansohm A, Brown JW. Temporary left-sided mechanical cardiac support during acute myocarditis. J Heart Lung Transplant 1994;13:268–70.
Marelli D, Laks H, Amsel B, et al. Temporary mechanical support with BVS 5000 assist device during treatment of acute myocarditis. J Card Surg 1997;12:55–59.
Reinhartz O, Hill JD, Al-Khaldi A, Pelletier MP, Robbins RC, Farrar DJ. Thoratec ventricular assist devices in pediatric patients: update on clinical results. ASAIO J 2005;51:501–3.
Grinda JM, Chevalier P, D’Attellis N, et al. Fulminant myocarditis in adults and children: biventricular assist device for recovery. Eur J Cardio-Thorac Surg 2004;26:1169–73.
Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001;122:440–8.
Acker MA. Mechanical circulatory support for patients with acute fulminant myocarditis. Ann Thorac Surg 2001;71:S73–6.
Chen, YS, Yu HY, Huang SC, et al. Experience and result extracorporeal membrane oxygenation in treating fulminant myocarditis with shock—what mechanical support should be considered first? J Heart Lung Transplant 2005;24:81–7.
Hetzer R, Potapov EV, Stiller B, et al. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients. Ann Thorac Surg 2006;82:917–24.
Davies RA, Veinot JP, Smith S, Struthers C, Hendry P, Masters R. Giant cell myocarditis: clinical presentation, bridge to transplantation with mechanical circulatory support, and long-term outcome. J Heart Lung Transplant 2002;21:674–9.
Nieminen MS, Bohm M, Cowie R, et al., for the European Society of Cardiology. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Eur Heart J 2005;26:384–416.
Lucas C, Johnson W, Hamilton MA, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 2000;140:840–7.
Stevenson LW, Miller LW, Desvigne-Nickens P, et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation 2004;110:975–81.
Kittleson M, Hurtzwitz S, Shah MR, et al. Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality. J Am Coll Cardiol 2003;41:2029–35.
Gracin N, Johnson MR, Spokas D, et al. The use of the APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation. J Heart Lung Transplant 1998;17:1017–23.
Stevenson LW, Shekar P. Ventricular assist devices for durable support. Circulation 2005;112:e111–5.
Deng MC, Edwards LB, Hertz MI, et al. Mechanical circulatory Support Device Database of the International Society for Heart and Lung Transplantation: third annual report—2005. J Heart Lung Transplant 2005;24:1182–7.
DiGiorgi PL, Rai V, Naka Y, Oz M. Which patient, which pump? J Heart Lung Transplant 2003;22:221–35.
Artrip JH, Yi GH, Burkhoff D, Wang J. Physiological and hemodynamic evaluation of non-uniform direct cardiac compression. Circulation 1999;100:II236–43.
Dowling RD, Gray LA Jr, Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 2004;127:131–41.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag London Limited
About this chapter
Cite this chapter
Tallaj, J.A., Pamboukian, S.V., Bourge, R.C. (2008). Role of Left Ventricular Assist Devices in Acute Heart Failure Syndrome and the Future of the Replacement Heart. In: Mebazaa, A., Gheorghiade, M., Zannad, F.M., Parrillo, J.E. (eds) Acute Heart Failure. Springer, London. https://doi.org/10.1007/978-1-84628-782-4_67
Download citation
DOI: https://doi.org/10.1007/978-1-84628-782-4_67
Publisher Name: Springer, London
Print ISBN: 978-1-84628-781-7
Online ISBN: 978-1-84628-782-4
eBook Packages: MedicineMedicine (R0)